(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MISSION PHARMACAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MISSION PHARMACAL

ST13

US500000086064503

Class

5

Filing

86064503

Registration

4750385

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

09/12/2025

Trademark type

Combined

Nice classes

5

Filing date

09/13/2013

Registration date

06/09/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/11/2025

Last transaction

09/12/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

11/20/2007

First use in commerce

11/20/2007

Drawing code

3

Owner type

03

Owner location

SAN ANTONIO, TX

Examiner

HOWARD, PARKER

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "MISSION" stacked on top of the word "PHARMACAL" with both words appearing to the right of an apothecaries' balance situated within a shaded box.

Holders and representatives

Holders

Mission Pharmacal Company
Mission Pharmacal Company

Representatives

Pamela B. Huff Schwegman Lundberg & Woessner P.A.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for use in treating allergic and dermatologic disordersa topically applied acne treatment; pharmaceutical ointment used for the prevention and treatment of rash; pharmaceutical preparations for use in the treatment and prevention of skin disorders; analgesic balm; prenatal multi-vitamins and multi-minerals

Publications

History of USPTO decisions and trademark events.

47 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/11/2025

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/11/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/11/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/11/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

05/12/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/27/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/27/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/27/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/27/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/27/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/10/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/31/2021

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/31/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/31/2021

E815

TEAS SECTION 8 & 15 RECEIVED

05/12/2021

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

03/03/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/08/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/08/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/08/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/08/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/08/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/09/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/07/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

06/09/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/29/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/24/2015

PUBO

PUBLISHED FOR OPPOSITION

03/24/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/04/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/17/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/14/2015

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/09/2015

ALIE

ASSIGNED TO LIE

02/04/2015

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

08/04/2014

ALIE

ASSIGNED TO LIE

08/04/2014

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/04/2014

GNSL

LETTER OF SUSPENSION E-MAILED

02/04/2014

CNSL

SUSPENSION LETTER WRITTEN

02/04/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/03/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/01/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/01/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/24/2013

GNRT

NON-FINAL ACTION E-MAILED

10/24/2013

CNRT

NON-FINAL ACTION WRITTEN

10/24/2013

DOCK

ASSIGNED TO EXAMINER

10/23/2013

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/24/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/23/2013

NWAP

NEW APPLICATION ENTERED

09/17/2013

Continuous trademark protection

Get notified about every new filing that threatens MISSION PHARMACAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.